Cornerstone Enterprises’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,618
Closed -$3.21M 34
2024
Q3
$3.21M Buy
3,618
+609
+20% +$548K 2.01% 13
2024
Q2
$2.72M Buy
3,009
+28
+0.9% +$22.4K 1.81% 15
2024
Q1
$2.27M Buy
+2,981
New +$2.12M 1.67% 18

Other funds holding LLY

Cornerstone Enterprises's LLY Position: Q4 2024 in Review

Cornerstone Enterprises sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 3,618 shares — an estimated $3.21M sold.

Cornerstone Enterprises first reported a position in LLY in Q1 2024 and held it in 3 quarters. The position peaked at $3.21M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Cornerstone Enterprises reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Cornerstone Enterprises sold 3,618 Eli Lilly shares in Q4 2024, an estimated $3.21M.
  • Cornerstone Enterprises first reported a position in Eli Lilly in Q1 2024 and held it in 3 quarters.
  • Cornerstone Enterprises's Eli Lilly position peaked at $3.21M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Cornerstone Enterprises's 13F filing for Q4 2024, filed 13 Feb 2025.